Cargando…

Radiation-induced late dysphagia after intensity-modulated radiotherapy in nasopharyngeal carcinoma patients: a dose-volume effect analysis

Dysphagia is a side effect of nasopharyngeal carcinoma chemo-radiotherapy (CRT) which greatly influences the quality of life of the patients. We analyzed late dysphagia in 134 patients with nasopharyngeal cancer undergoing radical radiotherapy (RT), and correlated these findings with dose–volume his...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Li, Huang, Chenhui, Gan, Yixiu, Wu, Tong, Tang, Xiaobi, Wang, Yiru, Wang, Rensheng, Zhang, Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219576/ https://www.ncbi.nlm.nih.gov/pubmed/30401941 http://dx.doi.org/10.1038/s41598-018-34803-y

Ejemplares similares

A retrospective dosimetry study of intensity-modulated radiotherapy for nasopharyngeal carcinoma: radiation-induced brainstem injury and dose-volume analysis
por: Yao, Cheng-Yun, et al.
Publicado: (2018)

Predictors of Mastoiditis after Intensity-Modulated Radiotherapy in Nasopharyngeal Carcinoma: A Dose-Volume Analysis
por: Yao, Ji-Jin, et al.
Publicado: (2016)

Dose-volume factors associated with ear disorders following intensity modulated radiotherapy in nasopharyngeal carcinoma
por: Yao, Ji-Jin, et al.
Publicado: (2015)

Radiation-induced temporal lobe injury after intensity modulated radiotherapy in nasopharyngeal carcinoma patients: a dose-volume-outcome analysis
por: Sun, Ying, et al.
Publicado: (2013)

Thyroid dose‐volume thresholds for the risk of radiation‐related hypothyroidism in nasopharyngeal carcinoma treated with intensity‐modulated radiotherapy—A single‐institution study
por: Huang, Cheng‐Long, et al.
Publicado: (2019)

Dose-volume relationships for moderate or severe neck muscle atrophy after intensity-modulated radiotherapy in patients with nasopharyngeal carcinoma
por: Zhang, Lu-Lu, et al.
Publicado: (2015)

Validation of the 8th edition of the UICC/AJCC staging system for nasopharyngeal carcinoma treated with intensity-modulated radiotherapy
por: Kang, Min, et al.
Publicado: (2017)

A prospective study on radiation doses to organs at risk (OARs) during intensity-modulated radiotherapy for nasopharyngeal carcinoma patients
por: Yao, Ji-Jin, et al.
Publicado: (2016)

A new staging system for nasopharyngeal carcinoma based on intensity-modulated radiation therapy (IMRT)
por: Kang, Min, et al.
Publicado: (2017)

Target volume and position variations during intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma
por: Tan, Wenyong, et al.
Publicado: (2013)

Results of the radiation dose of head, body and tail of hippocampus in nasopharyngeal carcinoma patients treated with intensity modulated radiotherapy
por: Zong-wen, Sun, et al.
Publicado: (2018)

Cervical oesophagostomy in patients with severe dysphagia following radiotherapy for nasopharyngeal carcinoma
por: Wang, Y-J, et al.
Publicado: (2014)

Target delineation and dose prescription of adaptive replanning intensity-modulated radiotherapy for nasopharyngeal carcinoma
por: Xie, Dehuan, et al.
Publicado: (2019)

Long-term survival and late complications of intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma
por: Kong, Fangfang, et al.
Publicado: (2018)

The Impact of Clinical Stage on Radiation Doses to Organs at Risk Following Intensity-modulated Radiotherapy in Nasopharyngeal Carcinoma: A Prospective Analysis
por: Xu, Lin, et al.
Publicado: (2016)

Intensity-modulated radiotherapy combined with endostar has similar efficacy but weaker acute adverse reactions than IMRT combined with chemotherapy in the treatment of locally advanced nasopharyngeal carcinoma
por: Kang, Min, et al.
Publicado: (2018)

Different Risk Target Volumes for Nasopharyngeal Carcinoma Treated with Simultaneous Integrated Boost Intensity-Modulated Radiotherapy
por: Wang, Fangzheng, et al.
Publicado: (2020)

Predicting Nomogram for Severe Oral Mucositis in Patients with Nasopharyngeal Carcinoma during Intensity-Modulated Radiation Therapy: A Retrospective Cohort Study
por: Liu, Zhibing, et al.
Publicado: (2022)

Predictors of radiation-induced hypothyroidism in nasopharyngeal carcinoma survivors after intensity-modulated radiotherapy
por: Zhai, Ruiping, et al.
Publicado: (2022)

Analysis of late toxicity in nasopharyngeal carcinoma patients treated with intensity modulated radiation therapy
por: Zheng, YingJie, et al.
Publicado: (2015)

Intermediate Dose-Volume Parameters, Not Low-Dose Bath, Is Superior to Predict Radiation Pneumonitis for Lung Cancer Treated With Intensity-Modulated Radiotherapy
por: Meng, Yinnan, et al.
Publicado: (2020)

Scheduling radiotherapy for patients with nasopharyngeal carcinoma in the corresponding time window can reduce radiation‐induced oral mucositis: A randomized, prospective study
por: Lv, Jun, et al.
Publicado: (2023)

Association between VEGF–460T/C gene polymorphism and clinical outcomes of nasopharyngeal carcinoma treated with intensity-modulated radiation therapy
por: Tan, Junyin, et al.
Publicado: (2017)

Prognostic value of total tumor volume in patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy
por: Liang, Shao-Bo, et al.
Publicado: (2017)

A new staging system for nasopharyngeal carcinoma based on intensity-modulated radiation therapy: results of a prospective multicentric clinical study
por: Kang, Min, et al.
Publicado: (2016)

The Impact of Reduced-Volume, Intensity-Modulated Radiation Therapy on Disease Control in Nasopharyngeal Carcinoma
por: Lin, Yu-Wei, et al.
Publicado: (2015)

Dysphagia after chemo-radiation for nasopharyngeal cancer: A scoping review
por: Fong, Raymond, et al.
Publicado: (2020)

Optimization of the margin expanded from the clinical to the planned target volume during intensity-modulated radiotherapy for nasopharyngeal carcinoma
por: Fangzheng, Wang, et al.
Publicado: (2017)

Half-Brain Delineation for Prediction of Radiation-Induced Temporal Lobe Injury in Nasopharyngeal Carcinoma Receiving Intensity-Modulated Radiotherapy
por: Du, Qing-Hua, et al.
Publicado: (2021)

Late toxicities after intensity-modulated radiotherapy for nasopharyngeal carcinoma: patient and treatment-related risk factors
por: Zeng, L, et al.
Publicado: (2014)

Failure Patterns of Recurrence and Metastasis After Intensity-Modulated Radiotherapy in Patients With Nasopharyngeal Carcinoma: Results of a Multicentric Clinical Study
por: Chen, Sixia, et al.
Publicado: (2022)

Tumor volume is an independent prognostic indicator of local control in nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy
por: Feng, Mei, et al.
Publicado: (2013)

An elective radiation dose of 46 Gy is feasible in nasopharyngeal carcinoma treated by intensity-modulated radiotherapy: A long-term follow-up result
por: Hung, Tsung-Min, et al.
Publicado: (2017)

Prognostic Significance of Tumor Volume in Locally Recurrent Nasopharyngeal Carcinoma Treated with Salvage Intensity-Modulated Radiotherapy
por: Xiao, WeiWei, et al.
Publicado: (2015)

Outcomes of patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy
por: Yeh, Shyh-An, et al.
Publicado: (2021)

Dysphagia in head and neck cancer patients following intensity modulated radiotherapy (IMRT)
por: Peponi, Evangelia, et al.
Publicado: (2011)

Analysis of intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma
por: Wu, Shihai, et al.
Publicado: (2020)

A nomogram for predicting late radiation-induced xerostomia among locoregionally advanced nasopharyngeal carcinoma in intensity modulated radiation therapy era
por: Yang, Kaixuan, et al.
Publicado: (2021)

Treatment outcomes and late toxicities of 869 patients with nasopharyngeal carcinoma treated with definitive intensity modulated radiation therapy: new insight into the value of total dose of cisplatin and radiation boost
por: Ou, Xiaomin, et al.
Publicado: (2015)

Plasma uric acid and tumor volume are highly predictive of outcome in nasopharyngeal carcinoma patients receiving intensity modulated radiotherapy
por: Lin, Hui, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_4otjrrrqh9v4ghv1hljjj68mc4